drugset / Trial / NCT00276250
Islet Transplantation Using Abatacept
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Islet transplantation in type 1 diabetics with hypoglycemic unawareness using abatacept as a part of a novel calcineurin-inhibitor-sparing immunosuppressive regimen.
Timeline
- Start
- 2005-12
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abatacept | Other / unclassified | — | Intravenous |
| Subject | Belatacept | Protein / enzyme biologic | — | Intravenous |
| Subject | efalizumab | Monoclonal antibody | — | Subcutaneous |